{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:29:45Z","timestamp":1765268985633,"version":"3.41.2"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The lockdown measures during the SARS-CoV-2 pandemic could have influenced drug consumption patterns of persons with drug use disorder, especially due to a reduced availability of drugs, an increased consumption of sedating substances as a coping strategy, or a shift to novel psychotropic substances (NPS) associated with an increased drug buying in the internet. In this study, the consumption patterns of people mainly with opioid use disorder entering inpatient drug detoxification treatment were investigated in the same hospitals with the same methods before and during the pandemic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>At admission, patients were interviewed regarding their consumption patterns using the EuropASI questionnaire. In addition, changes in the routes of drug acquisition were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In five hospitals in Western Germany, 213 (2021) and 175 persons (2018) were recruited. Sociodemographic data were similar in both cohorts (mean age around 40 years, mainly male, about 50% with migrant background, high unemployment rate). Rates of use of various drugs during the last 30 days were also similar. Differences were detected for gabapentinoids and opioid analgesics (increase &amp;gt;5%) as well as for cannabis (decrease &amp;gt;5%). Current use of NPS was low in both surveys. Only a minority of patients had experiences with drug acquisition in the internet.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The pandemic had only a minor influence on consumption patterns and routes of drug acquisition in this sample. It remains to be seen whether the increased use of gabapentinoids and opioid analgesics will continue despite the end of the pandemic.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2024.1467144","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T06:19:11Z","timestamp":1734329951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021"],"prefix":"10.3389","volume":"15","author":[{"given":"Patrik","family":"Roser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Specka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"K\u00fchnhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Steinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benita","family":"Zeiske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Deimel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"key":"B1","unstructured":"WHO Director-General\u2019s opening remarks at the media briefing on COVID-19\n          \n          \n          \n          2020"},{"key":"B2","unstructured":"Agreement between the Federal Government and the Federal States: Guidelines for the Control of the Corona Epidemic in Germany\n          \n          \n          \n          2020"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.11.covid19.1","article-title":"COVID-19 and substance use disorders: Recommendations for a comprehensive health care response","volume":"11","author":"Farhoudian","year":"2020","journal-title":"Basic Clin Neurosci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13446","article-title":"Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies","volume":"41","author":"Kilian","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109065","article-title":"The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review","volume":"228","author":"Schmidt","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00702-022-02564-8","article-title":"Cannabis use, abuse and dependence during the COVID-19 pandemic: A scoping review","volume":"130","author":"Bonnet","year":"2023","journal-title":"J Neural Transm"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912801","article-title":"Substance use and mental health during the first COVID-19 lockdown in Germany: Results of a cross-sectional survey","volume":"19","author":"Deimel","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/add.v116.8","article-title":"For better or for worse? A pre-post exploration of the impact of the COVID-19 lockdown on cannabis users","volume":"116","author":"Cousijn","year":"2021","journal-title":"Addiction"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108617","article-title":"Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder","volume":"221","author":"Jacka","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1037\/a0017324","article-title":"A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controls","volume":"23","author":"Hyman","year":"2009","journal-title":"Psychol Addict Behav"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.023","article-title":"End-of-day reports of daily hassles and stress in men and women with opioid-use disorder: Relationship to momentary reports of opioid and cocaine use and stress","volume":"193","author":"Preston","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.08.010","article-title":"Perceived stress and substance use in methadone-maintained smokers","volume":"133","author":"Moitra","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000363232","article-title":"Alcohol use disorders in opioid maintenance therapy: Prevalence, clinical correlates and treatment","volume":"21","author":"Soyka","year":"2015","journal-title":"Eur Addict Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychires.2021.05.006","article-title":"Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes","volume":"139","author":"Blithikioti","year":"2021","journal-title":"J Psychiatr Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000521425","article-title":"COVID-19 lockdown and consumption patterns among substance use disorder outpatients: A multicentre study","volume":"28","author":"Grau-L\u00f3pez","year":"2022","journal-title":"Eur Addict Res"},{"volume-title":"Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons: Results from an EMCDDA trendspotter study","year":"2021","key":"B16"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110144","article-title":"High lifetime, but low current, prevalence of new psychotropic substances (NPS) use in German drug detoxification treatment young inpatients","volume":"111","author":"Scherbaum","year":"2021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B18","article-title":"European addiction severity index EuropASI","volume-title":"Manual f\u00fcr Training und Durchf\u00fchrung","author":"Gsellhofer","year":"1999"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.648273","article-title":"Availability of illegal drugs during the COVID-19 pandemic in Western Germany","volume":"12","author":"Scherbaum","year":"2021","journal-title":"Front Psychiatry"},{"key":"B20","unstructured":"Trendspotter Briefing: Impact of COVID-19 on Patterns of Drug Use and Drug-Related Harms in Europe\n          \n          \n          \n          2020"},{"key":"B21","unstructured":"EMCDDA & Europol \u2013 EU Drug Markets \u2013 Impact of COVID-19\n          \n          \n          \n          2020"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s12103-022-09698-1","article-title":"Changes in online illegal drug buying during COVID-19: Assessing effects due to a changing market or changes in strain using a longitudinal sample design","volume":"47","author":"Hawdon","year":"2022","journal-title":"Am J Crim Just"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1196\/nyas.2008.1141.issue-1","article-title":"Chronic stress, drug use, and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/a-2230-3430","article-title":"Opioid maintenance treatment of opioid dependent persons during the COVID-19 pandemic \u2013 Regional results from Northrhine","volume":"25","author":"Schecke","year":"2024","journal-title":"Suchttherapie"},{"key":"B25","doi-asserted-by":"publisher","first-page":"114820","DOI":"10.1016\/j.socscimed.2022.114820","article-title":"COVID-19 vaccination, fear and anxiety: Evidence from Google search trends","volume":"297","author":"Awijen","year":"2022","journal-title":"Soc Sci Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/pathogens12020163","article-title":"COVID-19 vaccination and alcohol consumption: Justification of risks","volume":"12","author":"Solopov","year":"2023","journal-title":"Pathogens"},{"key":"B27","doi-asserted-by":"publisher","first-page":"14879","DOI":"10.3390\/ijerph192214879","article-title":"Use of alcohol, cannabinoids, psychostimulants, and sedatives before and during the COVID-19 pandemic among students in 40 European countries","volume":"19","author":"Babicki","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/add.v117.1","article-title":"Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: Findings from the Ecstasy and Related Drugs Reporting System, 2016-20","volume":"117","author":"Price","year":"2022","journal-title":"Addiction"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000321079","article-title":"Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data","volume":"80","author":"Schifano","year":"2011","journal-title":"Psychother Psychosom"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths \u2013 United States, 2000-2014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1467144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T06:19:16Z","timestamp":1734329956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1467144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":31,"alternative-id":["10.3389\/fpsyt.2024.1467144"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1467144","relation":{},"ISSN":["1664-0640"],"issn-type":[{"type":"electronic","value":"1664-0640"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"article-number":"1467144"}}